Home » Feedback (FDBK) » Feedback (FDBK) – Interim Results for 6 months ended 30 Nov 2015

Feedback (FDBK) – Interim Results for 6 months ended 30 Nov 2015

FBKlogoFeedback PLC (FDBK) – Interim Results for the six months ended 30 November 2015

Chairman’s Statement:

We are pleased to present the interim results for the six months ended 30 November 2015. Revenue for the six month period was £225,000 (2014: £229,000) and the loss after tax was £143,000. (2014: loss of £219,000). The loss before interest, tax and amortisation was £132,000 (2014: Loss £138,000). The cash balance as at 30 November 2015 was £164,000, (2014: £268,000).

The interim results show a small reduction in the loss for the period on similar levels of turnover to 2014. Cambridge Computed Imaging Limited again performed steadily as it continued to serve its established customer base. Revenue recognised from TexRAD research version sales in the six months was higher than in the comparable period in 2014, reflecting the contract wins that took place shortly before the end of the previous financial year. Revenue for the second half of the current financial year from TexRAD is also expected to be higher than in the comparable period. In line with management’s expectations, we have sold fewer research versions of TexRAD in recent months although there remains a good deal of customer interest from research institutions who are currently seeking grant funding. The Company has recently signed collaborative agreements with companies in Japan and South Korea to explore further selling opportunities in these markets for TexRAD research versions. The Company has also been looking to provide more support to research customers to assist them in analysing and interpreting the results of their studies. We have recently started work on one such project and this could prove to be a useful additional source of revenue in the future. Dr Balaji Ganeshan has been continuing his work supporting research into new potential applications of TexRAD. This has led to the publication of twelve peer-reviewed papers over the last year as well as a number of presentations at scientific conferences, including the Society of Cardiac MR Annual Scientific Sessions in Los Angeles last month.

In November 2015 the Company announced that it had signed a Memorandum of Understanding with Alliance Medical Group with the intention of integrating Feedback’s TexRAD texture analysis software into Alliance’s PET-CT lung cancer imaging service. The technical discussions have made good progress. A pilot implementation is currently underway and a retrospective study on a sample of studies with known clinical outcomes has shown promising preliminary results. The next stage will be to integrate with Alliance’s internal systems and evaluate our solution with multiple sites across the Alliance network. It is also anticipated that an abstract will be submitted to the Radiological Society of North America (RSNA) for intended publication at its annual conference in November 2016 which will highlight the results from the technical and clinical evaluation. Our development work with Alliance is considered to offer great potential as regards the future commercialisation of TexRAD software. Alliance and Feedback plan to undertake a multi-centre imaging research study to assess the use of TexRAD in lung cancer, with the eventual aim of gaining inclusion of texture analysis in the National Institute for Health and Care Excellence Lung Cancer pathway.

In 2015 the Company formed two joint venture companies, Stone Checker Software Ltd and Prostate Checker Ltd. These companies are at the stage of testing prototype versions of software containing TexRAD plug-ins, firstly on sample data sets and then on larger data sets. Both companies offer the prospect of developing innovative solutions where routine medical images can provide useful additional information for clinicians.

The Board believes the future for Feedback is hugely promising and we look forward to working closely with Alliance and developing our other collaborative ventures. We expect revenue in the second half of the current financial year to be broadly similar to the first half result. Operating expenses have been significantly reduced so when compared to the last financial year, the results for the current financial year are expected to show higher revenue and a reduced operating loss.

Tom Charlton

Chairman

Enquiries:


Feedback plc
Tom Charlton, Trevor Brown, 
Mike Hayball, Balaji Ganeshan
Tel: 01954 718072

Sanlam Securities UK Limited (Nominated advisor)
Simon Clements / James Thomas
Tel: 020 7628 2200
 

UNAUDITED INTERIM CONSOLIDATED INCOME STATEMENT

unaudited

unaudited

audited

6 months to

30 November 2015

6 months to

30 November 2014

Year to

31 May

2015

£’000

£’000

£’000

Revenue

225

229

382

Cost of sales

(2)

(42)

(1)

Gross profit

223

187

     381

Other operating expenses

(378)

(416)

        (889)

Impairment of intangible assets

        (689)

Total operating expenses

(378)

(416)

  (1,578)

Operating loss

 

(155)

 

(229)

 

  (1,197)

       

Net finance income

1

Loss before tax

(155)

(229)

  (1,196)

Tax credit

12

        10

            85

Loss for the period attributable to the equity shareholders of the parent

Loss on ordinary activities after tax

 

 

(143)

 

 

(219)

 

 

   (1,111)

Other comprehensive expense

Translation differences on overseas operations

 –

         –

Total comprehensive expense for the period

(143)

(219)

(1,111)

Basic and diluted earnings per share

 2

(0.07p)

(0.11p)

(0.58p)



UNAUDITED INTERIM CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

 

Share Capital

Share Premium

Capital Reserve

Retained Earnings

Translation Reserve

Convertible Debt Option Reserve

Total

£’000

£’000

£’000

£’000

£’000

£’000

£’000

Balance at 31 May 2014

477

1,409

300

(967)

(210)

189

1,198

Share option and warrant costs                                                                 

3

3

Total comprehensive income for the period

 

 

 

 

(219)

 

 

 

(219)

Balance at 30 November 2014

477

1,409

300

(1,183)

(210)

189

982

Share option and warrant costs                                                                 

(1)

(1)

Total comprehensive expense for the period

 

 

 

 

(892)

 

 

 

(892)

Balance at 31 May 2015

477

1,409

300

(2,076)

(210)

189

89

New shares issued

32

190

222

Costs associated with the raising of funds

(7)

(7)

Share option and warrant costs                                                                 

4

4

Total comprehensive income for the period

 

 

 

 

(143)

 

 

 

(143)

Balance at 30 November 2015

509

1,592

300

(2,215)

(210)

189

165

 

UNAUDITED INTERIM CONSOLIDATED STATEMENT OF FINANCIAL POSITION

 

unaudited

unaudited

audited

30 November 2015

30 November 2014

31 May

2015

£’000

£’000

£’000

ASSETS

Non-current assets

Property, plant and equipment

5

6

7

Intangible assets

125

839

140

Investments

5

135

       845

147

Current assets

Trade receivables

70

  160

 111

Other receivables

83

73

101

Cash and cash equivalents

164

268

63

317

501

275

Total assets

452

1,346

422

EQUITY

Capital and reserves attributable to the Company’s equity shareholders

Called up share capital

509

477

477

Share premium account

1,592

1,409

1,409

Capital reserve

300

300

300

Translation reserve

(210)

(210)

(210)

Retained earnings

(2,215)

(1,183)

(2,076)

(24)

798

(100)

Convertible debt option reserve

189

189

189

Total equity

165

982

89

LIABILITIES

Non-current liabilities

Deferred tax liabilities

24

70

28

Current liabilities

Trade payables

43

81

40

Other payables

220

213

265

263

294

305

Total liabilities

287

364

333

Net assets

452

1,346

422

UNAUDITED INTERIM CONSOLIDATED STATEMENT OF CASH FLOWS

 

unaudited

unaudited

audited

6 months to

30 November 2015

6 months to

30 November 2014

Year to

31 May

2015

£’000

£’000

£’000

Cash flows from operating activities

Loss before tax

(155)

(229)

(1,196)

Adjustments for:

Share option and warrant costs

4

3

1

Net finance income

(1)

Depreciation and amortisation

23

91

184

Impairment of intangible assets

689

Decrease/(increase) in trade receivables

41

(72)

(23)

Decrease in other receivables

26

49

52

Increase/(decrease) in trade payables

3

(145)

  (185)

Decrease in other payables

(45)

(217)

(164)

52

(291)

555

Net cash used in operating activities

(103)

(520)

(642)

Cash flows from investing activities

Purchase of tangible fixed assets

(6)

(9)

Purchase of intangible assets

(6)

(80)

(161)

Proceeds from sale of assets held for resale

1

Purchase of share in joint venture

(5)

Net cash used in investing activities

(11)

(86)

(169)

Cash flows from financing activities

Net proceeds from share issues

215

Net cash generated from financing activities

215

Net increase/(decrease) in cash and cash equivalents

101

(606)

(811)

Cash and cash equivalents at beginning of period

63

874

874

Cash and cash equivalents at end of period

164

268

63

 

FEEDBACK PLC

NOTES TO THE UNAUDITED INTERIM REPORT

1              BASIS OF PREPARATION

The consolidated interim financial statements have been prepared in accordance with the recognition and measurement principles of International Financial Reporting Standards as endorsed by the European Union (“IFRS”) and expected to be effective at the year end of 31 May 2016. The accounting policies are unchanged from the financial statements for the year ended 31 May 2015.

The information set out in this interim report for the six months ended 30 November 2015 does not comprise statutory accounts within the meaning of section 434 of The Companies Act 2006. The auditors’ report on the full statutory accounts for the period ended 31 May 2015 included an Emphasis of Matter paragraph in regard to Going Concern. The accounts for the period ended 31 May 2015 have been filed with the Registrar of Companies.

This interim report was approved by the directors on 19 February 2016.

2              LOSS PER SHARE

Basic earnings per share is calculated by reference to the loss on ordinary activities after and on the weighted average of shares in issue.

unaudited

unaudited

audited

As at 30 November 2015

 

As at 30 November 2014

 

As at 31 May 2015

 

£’000

£’000

£’000

Net loss attributable to ordinary equity holders

(143)

(219)

(1,111)

As at 30 November 2015

 

As at 30 November 2014

 

As at 31 May 2015

Weighted average number of ordinary shares for basic earnings per share

203,355,562

 

 

190,746,746

190,746,746

Effect of dilution:

Share Options

       Warrants

Weighted average number of ordinary shares adjusted for the effect of dilution

203,355,562

 

 

190,746,746

190,746,746

Loss per share (pence)

Basic and Diluted

(0.07)

(0.11)

(0.58)

3              INTANGIBLE ASSETS

Software

Customer relationships

Patents

Goodwill

Total

£’000

£’000

£’000

£’000

£’000

Cost

At 31 May 2014

435

100

41

272

848

Additions

64

16

80

At 30 November 2014

499

100

57

272

928

Additions

64

17

81

At 31 May 2015

563

100

74

272

1,009

Additions

6

6

At 30 November 2015

563

100

80

272

1,015

Amortisation

At 31 May 2014

Charge for the period

73

13

4

90

As at 31 November 2014

73

13

4

90

Charge for the period

72

12

6

90

Impairment charge in the year

418

272

689

At 31 May 2015

563

25

10

272

869

Charge for the period

13

7

20

At 30 November 2015

563

38

17

272

890

Net Book Value

At 30 November 2015

62

63

125

At 31 May 2015

75

65

140

At 30 November 2014

426

87

53

272

838

4              AVAILABILITY OF THE INTERIM REPORT

Copies of the report will be available from the Company’s office and also from the Company’s website www.fbk.com


Leave a comment

I would like to receive Brand Communications updates and news...
Free Stock Updates & News
I agree to have my personal information transfered to MailChimp ( more information )
Join over 3.000 visitors who are receiving our newsletter and learn how to optimize your blog for search engines, find free traffic, and monetize your website.
We hate spam. Your email address will not be sold or shared with anyone else.